Abstract
Introduction
The repair process in adults closely resembles normal development of the skeleton during embryogenesis, which occurs by intramembranous and endochondral ossification (Fig. 1) [1] . Nonetheless, some aspects are different from the foetal boneforming process, such as the contribution of inflammation, the scarcity of regenerative cells and the increased prevalence of mechanical forces in adults [2] [3] [4] . Of note, the inflammation in fracture healing process is an early event giving rise to signalling of pro-inflammatory cytokines crucial for the wound repair. [5] [6] [7] [8] .
Interleukin-1 (IL-1) and IL-6 as well as tumour necrosis factor-␣ (TNF-␣) carry out central functions in the induction of downstream responses to injury by having a chemotactic effect on other inflammatory cells, enhancing extracellular matrix synthesis, stimulating angiogenesis and recruiting endogenous fibrogenic cells to the injury site
The first step in endochondral ossification is the aggregation of mesenchymal cells into discrete condensations that resemble the shape of the future skeletal element. A similar process occurs during the early stages of fracture repair [9] .
After vascular damage, mesenchymal stem cells (MSCs) populate the wound site in hypoxic conditions, where they proliferate and then differentiate along a cartilaginous or an osteogenic lineage in response to growth factors and cytokines released by platelets, inflammatory cells and neighbouring cells and tissues. Indeed, within this process, it can be detected IL-1, IL-6, TNF-␣, transforming growth factor-␤ (TGF-␤) as pro-inflammatory molecules, whereas placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) are angiogeneic molecules, and fibroblast growth factor (FGF), bone morphogenetic proteins (BMPs), Indian hedgehog (Ihh) and
Wnt are differentiation inducing proteins [2, [10] [11] [12] [13] [14] [15] [16] [17] [17] . [18] [19] [20] [21] . [22] . MSCs 
. On the other hand, vascular damage induces angiogenesis or vasculogenesis by recruiting endothelial progenitors (EPCs) locally or after their circulation in blood. The VEGF/PlGF defect impairs their recruitment as well as their proliferation and differentiation

The defects of one of the factors mentioned above yield both delayed union and non-union. However, to date there is not a specific marker of the non-union which could be used as prognostic marker and the molecular mechanisms need to be clarified. This could be resolved by the knowledge of MSCs with capabilities to repair bone fracture in adult. In addition, there are convincing data showing that EPCs are also crucial for this process; however, BM EPCs are also poorly known. We review here recent data on MSC and EPC origins and characterization, and we depict their respective role in bone healing.
Mesenchymal stem cells as skeletal stem cells Cultured or expanded MSCs
In adult stages, multipotent skeletal stem cells, also referred to as MSCs or multipotential stromal cells (MSCs), contribute to the maintenance of various tissues, particularly bone. MSCs can be isolated from bone marrow (BM) and adipose tissues in adult stages and also from placenta and umbilical cord blood
MSCs can be induced in vitro and in vivo to differentiate into various mesenchymal tissues such as bone, cartilage, muscle, tendon, adipose tissue and haematopoiesis-supporting stroma. In addition, human BM-derived MSCs maintain their multipotent capacity and exhibit site-specific differentiation after in utero transplantation in sheep
Native MSCs
In contrast to cMSCs, only little information exists regarding the features of the primary precursors, nMSCs, that give rise to these plastic-adherent cells (Fig. 2). Various groups have attempted thus far to purify MSCs by using different strategies. Indeed, using the monoclonal antibody Stro-1 (recognizing an as-yet-unknown antigen), Simmons et al. identified nMSCs as CD34
ϩ cells and found them on the abluminal face of the vessels ( [49, 50] . CD49a is the ␣1 subunit of the VLA-1 integrin, a collagen IV and laminin receptor and was primarily described as an early marker of VSM cells in organogenesis [51] . Recently, our group demonstrated that nMSCs could also be enriched within the CD200 ϩ BM fraction [52] . [65, 66] . Moreover, inflammatory cytokines in aorta induce BMP2, which then promotes signalling through a muscle segment homeobox homolog (Msx2)/Wnt pathway leading to increased alkaline phosphatase activity and osteogenic differentiation [67] . Interestingly, Msx2 was shown to be a regulatory factor for VSM differentiation in one hand and osteoblastic cell differentiation on the other hand [68, 69] [18, [74] [75] [76] [77] . Native MSCs were also thought to be derived from surrounding skeletal muscle. This suggestion is a real possibility because MSCs might be obtained from multipotential myoblastic cells such as the well-known C2C12 murine cell line [78] . However, during secondary fracture healing, the primary source of nMSCs giving rise to the callus is thought to be periosteum, notably because (i ) callus development after fracture is strongly disturbed when the periosteum is removed and (ii ) the periosteum produces BMPs during early events following fracture [79, 80] . Furthermore, to date convincing data support the presence of functional nMSCs within the periosteum that have strong proliferative and osteogenic capabilities in vitro and in vivo [81] . Here also, vascularization is a crucial event for the initiation and propagation of the bone formation deriving from the periosteum. We can therefore suppose that periosteal nMSCs are located in the vessels and are induced to proliferate and differentiate into osteoblasts after fracture after vascular ingrowth into developing callus (Fig. 3) .
To date, no data exist on the strict purification of nMSCs (i.e. one selected cell generating one multipotent CFU-F). [18, 82, 83] [92, 93] . This is supported by data from reports of Takashima et 
new vessel formed from EPCs ingrow into lesion. Native MSCs are of perivascular origin and accompany new vessels into the cal. The hypertrophic chondrocytes (Hyp. Ch) are crucial elements forming the callus and inducing vascularization notably by their secretion of PlGF and VEGF. Native MSCs within cal or lesion proliferate and differentiate into osteoblastic cells capable to build up new bony structure (O). The bone can be repaired through intramembranous or endochondral ossification. In the intramembranous case, nMSCs condense before to form bone whereas in endochondral ossification nMSCs generate chondrocytes which in turn induce osteoblasts to form bone. multipotentiality, and no observational tests exist to discern differences among them
al. They showed that neural markers were not observed in cells derived from embryonic cells differentiated by mesodermal inducing conditions. On the other hand, neural markers and MSC differentiation capacities were both detected in cells cultured under neuroepithelial conditions [86]. Therefore, the potential of a population of BM MSCs to give rise to neural cells could depend only on its NC-derived cell content. During development, it would be very interesting to address this assumption directly on nMSCs according their expression of either neural (such as p75) or mesodermal markers (such as PDGF-R␤).
In [1, 13, 14, [94] [95] [96] [97] .
Vascularization and bone healing
In bone defects, there is a breaking in blood supply and the graft (generally constituted by regenerative cells and a scaffold) has to be locally vascularized as soon as possible to circumvent the failure. Indeed, to submit tissue or graft to hypoxic conditions and to the lack of nutrients will ultimately lead to cell death [98] . In rat, the critical bone defect filled with engineered scaffold provided bone formation which was increased when a vascularized periosteal flap was added and this also prevented heterotopic ossification [99] . Therefore, scientists performed new strategies to induce vascularization or to inhibit endothelial cell death. The addition of the anti-apoptotic Bcl2 gene into endothelial cells can increase survival and formation of blood-perfused blood vessels that develop into arteries, veins and capillaries [100] . In addition, immortalization of human dermal microvascular endothelial cells by hTERT results in the development of microvascular structures when implanted subcutaneously [101] . In another way, the use of a mixture consisting of perivascular cell precursors and endothelial cells in engineered constructs leads stable microvessels in vivo, which are fully functional for more than 1 year [102] . These 
